F. Greco

发表

Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancer.

J. Hainsworth, H. Burris, D. Spigel, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage II/III rectal cancer.

J. Hainsworth, J. Bendell, H. Burris, 2012, Clinical colorectal cancer.

Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer

J. Hainsworth, H. Burris, D. Yardley, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab.

J. Hainsworth, H. Burris, D. Yardley, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care

J. Hainsworth, F. Greco, John D. Hainsworth, 2014, Virchows Archiv.

Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.

Howard, J. Hainsworth, R. Hermann, 2004, The oncologist.

Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium.

J. Hainsworth, H. Burris, T. Mekhail, 2018, Lung cancer.

Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer.

K. Kelly, J. Crawford, Y. Oh, 2008, Lung cancer.

J. Hainsworth, F. Greco, L. Schwartzberg, 1997, Bone Marrow Transplantation.

Combined Modality Treatment With Chemotherapy, Radiation Therapy, Bevacizumab, and Erlotinib in Patients With Locally Advanced Squamous Carcinoma of the Head and Neck: A Phase II Trial of the Sarah Cannon Oncology Research Consortium

J. Hainsworth, D. Spigel, F. Greco, 2011, Cancer journal.

Phase II trial of docetaxal plus imatinib mesylate in the treatment of patients with metastatic breast cancer.

J. Hainsworth, H. Burris, D. Yardley, 2009, Clinical breast cancer.

Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction.

M. Erlander, J. Hainsworth, D. Yardley, 2010, The Oncologist.

Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.

J. Hainsworth, D. Spigel, F. Greco, 2013, Journal of the National Cancer Institute.

Curative Combination Chemotherapy for Patients with Advanced Poorly Differentiated Carcinoma of Unknown Primary Site

J. Hainsworth, F. Greco, Teddi W. Dial, 1988, American journal of clinical oncology.

Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial.

J. Hainsworth, H. Burris, D. Yardley, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine

Suzanne F. Jones, J. Hainsworth, J. Bendell, 2011, Cancer Chemotherapy and Pharmacology.

A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma

J. Hainsworth, J. Sosman, I. Puzanov, 2016, Pigment cell & melanoma research.

Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.

J. Hainsworth, H. Burris, D. Spigel, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.